CTI BioPharma Announces United Kingdom National Cancer Research Institute AML Cooperative Group Advances Tosedostat to Next Stage of “Pick-a-Winner” L

Protocollo
8518
Comunicato
20151124_8518.pdf
Azienda
CTI BIOPHARMA
Tipo
Comunicato
SDIR
SDIRNIS
Lingua
ENG
Data creazione
Data ricezione SDIR
Data diffusione SDIR
Mercato
Euronext Milan